UNSPSC 51322001: Colesevelam

This classification denotes an anti-lipidemic agent with the molecular formula (C13H27N)n.(C12H27ClN2)n.(C9H18N2O)n.(C3H7N)n, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XU104G55N, chemically known as 1-hexaminium, n,n,n-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and n-2-propenyl-1-decanamine, hydrochloride but generally known as colesevelam, which bears US NIH Compound Identifier 160051.

UNSPSC 51322001 Colesevelam, a Commodity-tier code, covers prescription pharmaceutical products supplied to state and local health systems, emergency services, and pharmacy benefit programs. The recent solicitation activity under this code shows state and local governments purchasing specific branded and generic medications for emergency medical services, state health agency programs, and multi-jurisdictional cooperative purchasing networks. Work being solicited includes supplying individual medication units to fire rescue departments, establishing direct-to-manufacturer prescription fulfillment arrangements for state pharmacy benefit programs, and providing generic multi-source pharmaceuticals and over-the-counter products through authorized wholesale distribution channels to member agencies across multiple states.

Issuing bodies include city purchasing departments (City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Geographic activity appears concentrated in Texas, Minnesota, Florida, and participating cooperative-member states including Oregon. Representative recent opportunities include the City of Tampa's sealed-bid solicitation (26P00188) for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000.00 and a response deadline of April 8, 2026; and MMCAP's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The Texas Health and Human Services Commission also issued an RFI (HHS0017013) exploring direct-to-manufacturer prescription programs as a preliminary market intelligence mechanism ahead of a formal procurement vehicle. Vendors supplying under this code must meet FDA compliance, expiration-dating requirements, and state-specific accessibility and safety documentation standards, including OSHA Safety Data Sheets and WCAG 2.2 accessibility conformance reporting in some instances.